Knut Sommerer

Robert Koch Allee 29
Gauting, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Regional Lung Deposition: In Vivo Data.

Regional Lung Deposition: In Vivo Data.

Journal: Journal of aerosol medicine and pulmonary drug delivery

Published: October 06, 2020

Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.

Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.

Journal: Journal of aerosol medicine and pulmonary drug delivery

Published: March 09, 2019

Lung Deposition of the Dry Powder Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Using NEXThaler® Device in Healthy Subjects, Asthmatic Patients, and COPD Patients.

Lung Deposition of the Dry Powder Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Using NEXThaler® Device in Healthy Subjects, Asthmatic Patients, and COPD Patients.

Journal: Journal of aerosol medicine and pulmonary drug delivery

Published: July 11, 2018

Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.

Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.

Journal: Respiratory medicine

Published: October 16, 2017

Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.

Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.

Journal: Journal of aerosol medicine and pulmonary drug delivery

Published: July 23, 2016

Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.

Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.

Journal: Journal of aerosol medicine and pulmonary drug delivery

Published: December 17, 2015

Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products.

Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products.

Journal: Journal of aerosol medicine and pulmonary drug delivery

Published: December 11, 2012

Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products.

Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products.

Journal: Journal of aerosol medicine and pulmonary drug delivery

Published: December 11, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026